[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Hyperimmunoglobulin 50 mg/kg: Participants will receive a dose of50 mg/kg body weight of COVID-19 hyperimmunoglobulin by intravenous route at the rate of not more than 0.5mL/kg/h on Day 1. This dose will be administered through a separate IV line.In addition to hyperimmunoglobulin patients will receive Standard of CareIntervention2: Hyperimmunoglobulin 75 mg/kg: Participants will receive a dose of 75 mg/kg body weight of COVID-19 hyperimmunoglobulin by intravenous route at the rate of not more than 0.5mL/kg/h on Day 1. This dose will be administered through a separate IV line.In addition to hyperimmunoglobulin patients will receive Standard of CareControl Intervention1: Standard of Care: Standard of care is the treatment algorithm/modalities to be given at discretion of the investigator as defined in the latest Guidelines on Clinical Management of COVID-19 issued by Ministry of Health and Family Welfare; Government of India; as on date", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Hyperimmunoglobulin 50 mg/kg: Participants will receive a dose of50 mg/kg body weight of COVID-19 hyperimmunoglobulin by intravenous route at the rate of not more than 0.5mL/kg/h on Day 1. This dose will be administered through a separate IV line.In addition to hyperimmunoglobulin patients will receive Standard of Care", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention2: Hyperimmunoglobulin 75 mg/kg: Participants will receive a dose of 75 mg/kg body weight of COVID-19 hyperimmunoglobulin by intravenous route at the rate of not more than 0.5mL/kg/h on Day 1. This dose will be administered through a separate IV line.In addition to hyperimmunoglobulin patients will receive Standard of Care", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of Care: Standard of care is the treatment algorithm/modalities to be given at discretion of the investigator as defined in the latest Guidelines on Clinical Management of COVID-19 issued by Ministry of Health and Family Welfare; Government of India; as on date", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "50 mg/kg", "treatment_id": 89, "treatment_name": "Anti-covid-19 hyperimmune globulin", "treatment_type": "Immunoglobulins sars-cov-2 specific", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "75 mg/kg", "treatment_id": 89, "treatment_name": "Anti-covid-19 hyperimmune globulin", "treatment_type": "Immunoglobulins sars-cov-2 specific", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Hyperimmunoglobulin 50 mg/kg: Participants will receive a dose of50 mg/kg body weight of COVID-19 hyperimmunoglobulin by intravenous route at the rate of not more than 0.5mL/kg/h on Day 1. This dose will be administered through a separate IV line.In addition to hyperimmunoglobulin patients will receive Standard of CareIntervention2: Hyperimmunoglobulin 75 mg/kg: Participants will receive a dose of 75 mg/kg body weight of COVID-19 hyperimmunoglobulin by intravenous route at the rate of not more than 0.5mL/kg/h on Day 1. This dose will be administered through a separate IV line.In addition to hyperimmunoglobulin patients will receive Standard of CareControl Intervention1: Standard of Care: Standard of care is the treatment algorithm/modalities to be given at discretion of the investigator as defined in the latest Guidelines on Clinical Management of COVID-19 issued by Ministry of Health and Family Welfare; Government of India; as on date", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Hyperimmunoglobulin 50 mg/kg: Participants will receive a dose of50 mg/kg body weight of COVID-19 hyperimmunoglobulin by intravenous route at the rate of not more than 0.5mL/kg/h on Day 1. This dose will be administered through a separate IV line.In addition to hyperimmunoglobulin patients will receive Standard of Care", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention2: Hyperimmunoglobulin 75 mg/kg: Participants will receive a dose of 75 mg/kg body weight of COVID-19 hyperimmunoglobulin by intravenous route at the rate of not more than 0.5mL/kg/h on Day 1. This dose will be administered through a separate IV line.In addition to hyperimmunoglobulin patients will receive Standard of Care", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of Care: Standard of care is the treatment algorithm/modalities to be given at discretion of the investigator as defined in the latest Guidelines on Clinical Management of COVID-19 issued by Ministry of Health and Family Welfare; Government of India; as on date", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]